NCT00004250View on ClinicalTrials.gov

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

June 30, 2007

Conditions

Melanoma (Skin)Sarcoma

Interventions

BIOLOGICAL

dactinomycin

DRUG

isolated limb perfusion

DRUG

melphalan

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004250 - Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter